Hosted on MSN8h
Are Options Traders Betting on a Big Move in Elevance Health (ELV) Stock?
Investors in Elevance Health, Inc. ELV need to pay close attention to the stock based on moves in the options market lately. That is because the June 20, 2025 $270Call had some of the highest implied ...
CVS Health price target raised to $74 from $58 at RBC Capital
RBC Capital analyst Ben Hendrix raised the firm’s price target on CVS Health (CVS) to $74 from $58 and keeps an Outperform rating on the ...
Andrew Price Executes Sell Order: Offloads $495K In Encompass Health Stock
Andrew Price, Chief Accounting Officer at Encompass Health EHC, disclosed an insider sell on February 13, according to a recent SEC filing. What Happened: A Form 4 filing with the U.S. Securities and ...
Elevance Health Inc. stock outperforms competitors on strong trading day
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...
Here’s Why Elevance Health (ELV) Slid in Q4
GreensKeeper Asset Management, an investment management company, released its fourth quarter investor letter. A copy of the ...
Elevance Health, Inc. (NYSE:ELV) Given Average Recommendation of “Moderate Buy” by Analysts
Elevance Health, Inc. (NYSE:ELV – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the sixteen brokerages that are currently covering the company, Marketbeat.com reports.
Cantor Fitzgerald maintains Humana stock Neutral rating and $290 target
Cantor Fitzgerald reaffirmed its Neutral stance on Humana (NYSE:HUM) stock, maintaining the price target at $290.00. The stock, currently trading at $257.34, has experienced a significant 11.4% ...